Diltiazem HCl Extended Release Capsules, USP 120 mg, 500 count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505. NDC 0378-5220-05.
Published September 3, 2014 · Recall initiated: June 19, 2014
Summary
FDA records drug Class III recall D-1557-2014, published September 3, 2014 and initiated June 19, 2014. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 2,658 Bottles; Lot: Lot 3040063 Exp. 07/14. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: High out-of-specification results for a related compound obtained during routine stability testing.
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Distributor
- Nationwide
- Lot
- Lot 3040063 Exp. 07/14
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACandesartan Cilexetil and Hydrochlorothiazide Tablets, USP 32 mg/12.5 mg, packaged in a) 90-count bottles (NDCOctober 28, 2020
- FDATacrolimus Capsules, USP 5mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDCApril 1, 2020
- FDASotalol HCL Tablets, USP (AF) 80 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals Inc. Morgantown, WVMarch 25, 2020
- FDANizatidine Capsules, USP 150 mg, Rx Only, Mylan Pharmaceuticals Inc., NDC 0378-5150-91.January 29, 2020
- FDAVIVITROL (naltrexone for extended-release injectable suspension); 380 mg vial NDC 65757-300-01; RX OnlySeptember 3, 2014
- FDANicotine Polacrilex Lozenge, 2 mg Mint Mini. 27 Ct Tubes, Over the Counter. Perrigo, 502 Eastern Ave, PlantSeptember 3, 2014
Questions about this recall
Was Diltiazem HCl Extended Release Capsules, USP 120 mg, 500 count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505. NDC 0378-5220-05. recalled?
Yes. FDA published recall D-1557-2014 on September 3, 2014. Reported hazard: Failed Impurities/Degradation Specifications: High out-of-specification results for a related compound obtained during routine stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone